|
|
|
EASL SLD Summit 2027 |
149 days left
|
| EASL Steatotic Liver Disease Summit |
| Dates:
Wednesday, February 10, 2027 - Saturday, February 13, 2027
|
| Venue: Berlin,
Berlin,
Germany |
|
|
The EASL Steatotic Liver Disease Summit 2027 comprises two complementary parts.
Part 1: EASL MASH Innovation and Implementation Roadmap (10 February) brings together stakeholders to define implementation priorities and regulatory perspectives for MASH care across Europe.
Part 2: Main Steatotic Liver Disease Summit Programme (11-13 February) is a three-day translational meeting that follows steatotic liver disease across its full continuum'-'from population policy to the patient in clinic, and from tissue microenvironment to the single stressed hepatocyte and its organelles.
Across ten thematic sessions, three State-of-the-Art lectures, a dedicated best-abstract session, and eight ePoster sessions, the programme deliberately refuses to separate "basic" from "clinical." The same disease spectrum'-'MASLD, MetALD and ALD'-'is interrogated at every scale by epidemiologists, hepatologists, pathologists, and cell and mechano-biologists.
The premise is that SLD is now a public-health problem with unresolved mechanistic and methodological foundations. The Summit therefore pairs the field's most pressing questions (Has renaming the disease changed anything? Can a liver stiffness score predict outcomes? Can we still justify placebo arms?) with the biological and mechanistic insights that will shape future answers. Designed for all stakeholders in the SLD community, the Summit provides a comprehensive update on the latest evidence, emerging data, and key developments across the field.
|
Website: https://easl.eu/event/easl-sld-summit-2027/
|
|
|
|
|
